Covis Pharmaceuticals Covis Pharmaceuticals is a specialty pharmaceutical company that provides therapeutic services. | ![]() Vernalis Vernalis (R&D) is a pharmaceutical company engaged in the research, development, and commercialization of pharmaceutical products. | ![]() Cell Signaling Technology Cell Signaling Technology is a company that develops and produces research products. | |||
Founding Date | Founding Date 2011 | Founding Date N/A | Founding Date 1997 | Founding Date 1994 | Founding Date 1999 |
Type | Type Private | Type Subsidiary | Type Subsidiary | Type Private | Type Private |
Tags | |||||
Locations | Locations Luxembourg, LU HQ Mississauga, CA Amsterdam, NL Zug, CH Berkeley Heights, US King Of Prussia, US Waltham, US | Locations Chippenham, GB HQ Saint Quentin Fallavier, FR Gauting, DE München, DE Muttenz, CH London, GB London, GB see more | Locations Cambridge, GB HQ | Locations Tehran, IR HQ | Locations Danvers, US HQ Chiyoda City, JP Leiden, NL Leiden, NL Beverly, US Boston, US |
Employees | Employees 4964% decrease | Employees 502 | Employees 242 | Employees 529 | Employees 1,8141% decrease |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) £12m (FY, 2018) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods £223k (FY, 2018) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit £2.3m (FY, 2022) | Gross profit £11.8m (FY, 2018) | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income (£158m) (FY, 2022) | Net income (£5.3m) (FY, 2018) | Net income N/A | Net income N/A |

Vectura Group is a product development company that focuses on drug delivery.
View company
Vernalis (R&D) is a pharmaceutical company engaged in the research, development, and commercialization of pharmaceutical products.
View company
Cell Signaling Technology is a company that develops and produces research products.
View company